-
October 26: The Week in Cancer NewsResearchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.
by Kate Yandell
-
October 19: The Week in Cancer NewsA study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
by Kate Yandell
-
October 12: The Week in Cancer NewsA study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
-
October 5: The Week in Cancer NewsCancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
by Kate Yandell
-
September 28: The Week in Cancer NewsA study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
-
September 21: The Week in Cancer NewsPatients weigh in on the impact of end-of-treatment bells in cancer centers, and a study suggests that current protocols for BRCA screening may miss testing some patients with mutations.
by Kate Yandell
-
September 14: The Week in Cancer NewsAn article sparks discussion about precision medicine hype, and a study tallies the rare fatal side effects of immune checkpoint inhibitors.
by Kate Yandell
-
September 7: The Week in Cancer NewsA study quantifies gains in breast cancer survival in young women, and a cancer doctor reflects on her experience as a cancer patient.
by Kate Yandell
-
August 31: The Week in Cancer NewsA study discusses the harms of breast cancer surgery for women in nursing homes, and an oncologist reflects on the use of military metaphors in writing about John McCain's cancer.
by Kate Yandell
-
August 24: The Week in Cancer NewsResearchers investigate how often retailers sell cigarettes to minors, and a trial shows the benefits of immunotherapy for melanoma patients with brain metastases.
by Kate Yandell
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
